Türkay Toklu

8PUBLICATIONS
27CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Astroparticle physics and particle cosmologyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 09, 2025
Istanbul PSMA PET/CT criteria (IPPC): an imaging-based approach to patient selection for active surveillance.

Levent Kabasakal, Kaan Akçay, Alan Nalan Selçuk

|Sep 29, 2025
The role of [⁶⁸Ga]Ga-FAP-2286 PET/CT in the evaluation of treatment response in gastrointestinal system malignancies.

Nalan Alan Selcuk, Gamze Beydagi, Kaan Akcay

|Feb 07, 2025
Improved Accuracy and Reliability of PRIMARY Scoring Using Delayed [68Ga] Ga-PSMA PET/CT Imaging.

Kaan Akçay, Gamze Beydağı, Onur Erdem Şahin

|Dec 19, 2023
Prediction of clinically significant prostate cancer by [68 Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance.

Kaan Akcay, Ali Kibar, Onur Erdem Sahin

|Oct 23, 2023
Initial Findings on the Use of [225Ac]Ac-DOTATATE Therapy as a Theranostic Application in Patients with Neuroendocrine Tumors.

Emre Demirci, Nalan Alan Selçuk, Gamze Beydağı

|Jun 30, 2022
Almost Complete Response with a Single Administration 225Ac-DOTATATE in a Patient with a Metastatic Neuroendocrine Tumor of Unknown Primary.

Nalan Alan Selçuk, Emre Demirci, Meltem Ocak

Pageof 2

Frequent Collaborators

8 joint publications

Levent Kabasakal

6 joint publications

Nalan Selçuk

6 joint publications

Gamze Beydağı

6 joint publications

Kaan Akçay